Example: marketing
CONSUMER MEDICINE INFORMATION - Medsafe
Consumer Medicine Information . Page 1 of 6 . ORATANE® Ask your doctor if you have any questions about . Isotretinoin . 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Capsules
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Prescriber Isotretinoin Educational Kit - …
www.ipledgeprogram.comWARNING Isotretinoin must not be used by female patients who are or may become pregnant. There is an extremely high risk that severe birth defects will result if pregnancy occurs while taking isotretinoin in any
ISOTRETINOIN - FEMALE
www.bad.org.uk4 Fitzroy Square, London W1T 5HQ Tel: 020 7383 0266 Fax: 020 7388 5263 e-mail: admin@bad.org.uk Registered Charity No. 258474 ISOTRETINOIN - FEMALE
New Zealand Data Sheet - Medsafe
www.medsafe.govt.nz6 | P a g e Benign intracranial hypertension Rare cases of benign intracranial hypertension have been reported after isotretinoin and after tetracyclines, See Section 4.8.
A Review on a Third Generation Retinoidal Agent: …
www.ijpacr.comISSN 2395-3411 Available online at www.ijpacr.com 16 International Journal of Pharma And Chemical Research I Volume 2 I Issue 1 I Jan – Mar I 2016
Photosensitizing Medication List - Vitiligo Support
www.vitiligosupport.orgt a n n i n g f a c t b o o k 2 0 0 8 / 2 0 0 9 c h a p t e r t w o 23 looking fit lookingfit.com * Non-steroidal anti-inflammatory drug Reported Photosensitizing Medications
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL …
www.ema.europa.eucpmp/2846/03 7/21 emea 2003 scientific conclusions overall summary of the scientific evaluation of roaccutane and associated names (see annex i)
D r u g N e w s - drugoffice.gov.hk
www.drugoffice.gov.hkDrug Office, Page 2 Department of Health, Hong Kong SAR Safety Update EU: Women taking Esmya for uterine fibroids to have regular liver tests while
Donor Educational Materials - LifeSouth
www.lifesouthcenters.orgJul 2009 (yellow version) Thank you for supporting your community’s blood supply. Donor Educational Materials Contents Responsibilities of a Blood Donor_____1
SHAPE A SCHEDULE OF BENEFITS - Colina e-Claims …
colina-eclaims2.benefits2pt0.comSHAPE A SCHEDULE OF BENEFITS Exclusions No benefits are payable for: 1. The evaluation of routine and other treatment of learning disabilities;